Via the Hong Kong government website: Typhoid vaccine recalled. Excerpt:
The Department of Health today instructed licensed drug wholesaler, Sanofi-Aventis Hong Kong, to recall typhoid vaccine Typhim VI from the market because of a quality issue.
Sanofi informed the department today that according to the French manufacturer, several out-of-specification test results regarding the antigen content were reported for Typhim VI, which might affect the efficacy of the vaccine.
The vaccine had been supplied to the department’s clinics, private doctors, private hospitals and pharmacies, and exported to Macau.
The department has asked Sanofi to provide a detailed investigation report on the cause of the incident.
